Coating Module Supports Easy Module Exchange

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-07-02-2017
Volume 41
Issue 7
Pages: 12

Tablet coating from DISONA can handle batch sizes up to 3 kg.

The new tablet coating module for the Minilab XP from DIOSNA supports easy module exchange, without the need for disassembling. The module is available for batch sizes from 500 g up to 3 kg. The module is equipped with a glass lid for process observation. Both modules are operated by a full graphical display, which allows for a change between manual and automatic modes. 

DIOSNA

 

 

Download Issue PDF
Articles in this issue
Packaging Improves Medication Adherence
Packaging Improves Medication Adherence
The New World of Biopharmaceutical Manufacturing
The New World of Biopharmaceutical Manufacturing
Forty Years of Drug Product Manufacturing Advances
Forty Years of Drug Product Manufacturing Advances
PT0717_Cover_200.jpg
Evolution of Dosage-Form Development and Manufacturing Strategies
Advances in Analytical Testing Tools for the Bio/Pharma Industry
Advances in Analytical Testing Tools for the Bio/Pharma Industry
PT0717_spotlignt_Ross_42N-36S.jpg
Ribbon Blenders for Specialty Applications
PT0717_spotlight_doisna_MiniCoater.jpg
Coating Module Supports Easy Module Exchange
PT0717_ProdSpotlight_distek.jpg
Dissolution Tester Eliminates Water Bath
PT0717_spotlight_sartorius_biostat_str_500.jpg
Bioreactor Family Includes Single-Use Bags
FDA Continues to Promote Quality Drug Production
FDA Continues to Promote Quality Drug Production
A 30-Year History of PLG Applications in Parenteral Controlled Drug Release
A 30-Year History of PLG Applications in Parenteral Controlled Drug Release
Coatings Sweeten Pharma Tablet Production
Coatings Sweeten Pharma Tablet Production
PT0717_Cover_200-6.jpg
Continuous API Manufacturing
PT0717_OSD_fig3Innopharma_250.jpg
Moving Toward Real-Time Release Testing
PT0717_Cover_200-8.jpg
Advances in ADCs
Recent Videos
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Behind the Headlines episode 6
Behind the Headlines episode 5
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Orexo and Abera Partner to Develop Nasal Powder Vaccines

Feliza Mirasol
December 20th 2024
Article

The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novo Nordisk to Establish New Production Facility for Rare Disease Therapies in Denmark with DKK 8.5 Billion Investment

Feliza Mirasol
December 17th 2024
Article

Novo Nordisk will use the DKK 8.5 billion (US$1.2 billion) to build a new modular and flexible production facility in Odense, Denmark, that will produce multiple products for rare diseases.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Novo Nordisk Gains Manufacturing Sites from Novo Holdings and Novavax while EC Approves Catalent Acquisition

Feliza Mirasol
December 11th 2024
Article

The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.

3D printed pills and drugs, future of medicine. 3D Printing Drugs In Pharmacies. Multi-colored, various drugs, pills, capsules. Pharmaceutical medical concept | Image Credit: © irissca - © irissca - stock.adobe.com

Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications

Gary Ritchie;Sharon Flank
December 10th 2024
Article

This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.